In addition, it is acknowledged that inhibiting MELK, as a pivotal gene in breast cancer, can reduce cell division by suppressing the expression of cyclin B and D170 and increasing the sensitivity of breast cancer tumors to chemo- and radiotherapy92. The gene discussed is MELK; the disease is breast carcinoma.